Thromboxane B2

Home
About
Help
History (1)
- Thromboxane B2
- See All Pages

"Thromboxane B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).

Descriptor ID	D013929
MeSH Number(s)	D10.251.355.255.100.825.810 D10.251.355.310.166.971.810
Concept/Terms	Thromboxane B2 Thromboxane B2 B2, Thromboxane

Below are MeSH descriptors whose meaning is more general than "Thromboxane B2".

Chemicals and Drugs [D]
Lipids [D10]
Fatty Acids [D10.251]
Fatty Acids, Unsaturated [D10.251.355]
Eicosanoids [D10.251.355.255]
Arachidonic Acids [D10.251.355.255.100]
Thromboxanes [D10.251.355.255.100.825]
Thromboxane B2 [D10.251.355.255.100.825.810]
Fatty Acids, Essential [D10.251.355.310]
Arachidonic Acids [D10.251.355.310.166]
Thromboxanes [D10.251.355.310.166.971]
Thromboxane B2 [D10.251.355.310.166.971.810]

Below are MeSH descriptors whose meaning is related to "Thromboxane B2".

Below are MeSH descriptors whose meaning is more specific than "Thromboxane B2".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Thromboxane B2" by people in this website by year, and whether "Thromboxane B2" was a major or minor topic of these publications.

Bar chart showing 12 publications over 10 distinct years, with a maximum of 2 publications in 2017 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2005	0	1	1
2006	0	1	1
2009	0	1	1
2012	1	0	1
2013	0	1	1
2015	1	0	1
2016	1	0	1
2017	1	1	2
2022	0	2	2

Below are the most recent publications written about "Thromboxane B2" by people in Profiles.

Hariri E, Kakouros N, Bunsick DA, Russell SD, Mudd JO, Laws K, Lake MW, Rade JJ. Nonplatelet thromboxane generation is associated with impaired cardiovascular performance and mortality in heart failure. Am J Physiol Heart Circ Physiol. 2022 07 01; 323(1):H248-H255.

View in: PubMed
Rade JJ, Barton BA, Vasan RS, Kronsberg SS, Xanthakis V, Keaney JF, Hamburg NM, Kakouros N, Kickler TA. Association of Thromboxane Generation With Survival in Aspirin Users and Nonusers. J Am Coll Cardiol. 2022 07 19; 80(3):233-250.

View in: PubMed
Kakouros N, Gluckman TJ, Conte JV, Kickler TS, Laws K, Barton BA, Rade JJ. Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery. J Am Heart Assoc. 2017 Nov 02; 6(11).

View in: PubMed
Bhatt DL, Grosser T, Dong JF, Logan D, Jeske W, Angiolillo DJ, Frelinger AL, Lei L, Liang J, Moore JE, Cryer B, Marathi U. Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2017 Feb 14; 69(6):603-612.

View in: PubMed
Kakouros N, Nazarian SM, Stadler PB, Kickler TS, Rade JJ. Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. J Am Heart Assoc. 2016 Mar 15; 5(3):e002615.

View in: PubMed
Brun C, Daali Y, Combescure C, Zufferey A, Michelson AD, Fontana P, Reny JL, Frelinger AL. Aspirin response: Differences in serum thromboxane B2 levels between clinical studies. Platelets. 2016; 27(3):196-202.

View in: PubMed
DeFilippis AP, Oloyede OS, Andrikopoulou E, Saenger AK, Palachuvattil JM, Fasoro YA, Guallar E, Blumenthal RS, Kickler TS, Jaffe AS, Gerstenblith G, Schulman SP, Rade JJ. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. Circ J. 2013; 77(11):2786-92.

View in: PubMed
Olson MT, Kickler TS, Lawson JA, McLean RC, Jani J, FitzGerald GA, Rade JJ. Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk. J Thromb Haemost. 2012 Dec; 10(12):2462-9.

View in: PubMed
Frelinger AL, Li Y, Linden MD, Barnard MR, Fox ML, Christie DJ, Furman MI, Michelson AD. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization. Circulation. 2009 Dec 22; 120(25):2586-96.

View in: PubMed
Frelinger AL, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation. 2006 Jun 27; 113(25):2888-96.

View in: PubMed

People

Explore

Similar Concepts

Top Journals